Plant Summary
TCMBank_ID: | TCMBANKHE002973 |
ID: | TCMBANKHE002973 |
植物拉丁名: |
|
功能与主治: | Treament of various febrile diseases, diarrhea, impetigo, liver and gallbladder diseases, debility during convalescence./Treament of various febrile diseases, diarrhea, impetigo, liver and gallbladder diseases, debility during convalescence. |
药用植物名: | 毛诃子 |
药用部位: | Terminalia bellerica (Gaertn.) Roxb. |
药味: | Mild; Sweet; Punkery |
TCM_ID_id: | 3300 |
TCMSP_id: | 508 |
化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
---|
TCMBANKIN000562 | tannins | Quebracho extract; 28F9E0DJY6; 67167-65-1; 1041198-33-7; TANNIC ACID; 61790-06-5; 1401-55-4; Tannins; Tannic acid [USP:JAN]; Acide tannique; SCHEMBL17432880; d'Acide tannique; 1041198-44-0; Gallotannic acid; 93615-37-3; UNII-28F9E0DJY6; 73891-88-0 | C27H24O18 | 636.5 g/mol | C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)O |
TCMBANKIN008134 | 3-O-β-D-galactopyrano-syl-(1-4)-O-α-L-rhamnopyranoside[3] | ||||
TCMBANKIN009033 | lignans | C22H22O8 | 414.4 g/mol | COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O | |
TCMBANKIN012486 | Anolignan B | C18H18O2 | 266.3 g/mol | C=C(CC1=CC=C(C=C1)O)C(=C)CC2=CC=C(C=C2)O | |
TCMBANKIN017418 | 2α,3β,23,29-tetrahydroxyolean-12-en-28-oicacid 29-o-β-d-glucopyranoside | C36H58O11 | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1)C)C(=O)O)COC6C(C(C(C(O6)CO)O)O)O | ||
TCMBANKIN024171 | Non chebulinic ellagic acid tannin | ||||
TCMBANKIN032059 | its β-d-glucopyranosyl es-te | ||||
TCMBANKIN032096 | triterpenoidsaponin | triterpenoid saponin | 767.07 | CC1C2C(C(C(O1)OC3C(C(COC3OC(=O)C45CCC(CC4(C6=CCC7(C(C6(CC5)C)(CCC8C7(CC(C(C8(C)CO)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)C(=O)CC(CC(=O)O2)(C)O)O)O)O)O)C)C)C)C)(C)C)O)O)O)OC1C(C(C(CO1)O)O)O | |
TCMBANKIN036901 | myristic acid | 1-Tridecanecarboxylic acid; Myristinsaeure; CH3-[CH2]12-COOH; 70079_FLUKA; AI3-15381; LMFA01010014; CH3-[CH2]12-COO(-); NCGC00091068-02; Myristic acid-[9,10-3H]; C06424; Emery 655; myristic acid ; NSC 5028; 70082_FLUKA; C14 fatty acid; ST023797; W276405_ALDRICH; CCRIS 4724; Kortacid 1499; 3uev; TUNFSRHWOTWDNC-UHFFFAOYSA-M; Tetradecanoic acid; EINECS 250-924-5; n-Tetradecoic acid; 4-02-00-01126 (Beilstein Handbook Reference); Hydrofol acid 1495; MYR; BRN 0508624; Myristate; Myristic acid (natural); Tetradecanoate; LS-190125; Crodacid; Myristic acid (8CI); EINECS 208-875-2; Prifac 2942; Myristic acid; AIDS002505; tetradecoate; W276413_ALDRICH; FEMA No. 2764; HSDB 5686; Philacid 1400; CHEBI:28875; Edenor C 14; n-tetradecoate; 45184-05-2; myristicacid; tetradecoic acid; n-Tetradecanoic acid; M3128_SIGMA; AIDS-002505; Univol U 316S; Lead dimyristate; AC1N2PSK; NCGC00091068-01; neo-Fat 14; NSC5028; Tetradecanoic acid (9CI); Hystrene 9014; Myristic acid, pure; M4792_SIGMA; CHEBI:30807; n-Tetradecan-1-oic acid; WLN: QV13; 1-tetradecanecarboxylate; 32112-52-0; n-tetradecan-1-oate; 544-63-8 | C14H28O2 | 228.371 | C([H])([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] |
TCMBANKIN037206 | Simiarenol | 6OU4M247SJ; MolPort-035-706-328; (3R,3AR,5AR,5BS,9S,11AS,11BR,13AS,13BR)-3-ISOPROPYL-3A,5A,8,8,11B,13A-HEXAMETHYL-1H,2H,3H,4H,5H,5BH,6H,9H,10H,11H,11AH,12H,13H,13BH-CYCLOPENTA[A]CHRYSEN-9-OL; (3R,3aR,5aR,5bS,9S,11aS,11bR,13aS,13bR)-3a,5a,8,8,11b,13a-hexamethyl-3-(propan-2-yl)-2,3,3a,4,5,5a,5b,6,8,9,10,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-ol; Simiaren-3beta-ol; ZINC56874814; CHEBI:81371; DTXSID00167162; SCHEMBL2337338; Simiarenol; D:B-Friedo-B':A'-neogammacer-5-en-3-ol, (3beta)-; W2408; 1615-94-7; beta-Simiarenol; C17901; BG01135934; UNII-6OU4M247SJ; AKOS032948287 | 426.72 | ||
TCMBANKIN044151 | thannilignan | C19H22O5 | 330.4 g/mol | COC1=CC(=C(C=C1)CC(CO)(C(=C)CC2=CC=C(C=C2)O)O)O | |
TCMBANKIN047300 | termilignan | C19H20O3 | 296.4 g/mol | COC1=CC(=C(C=C1)CC(=C)C(=C)CC2=CC=C(C=C2)O)O | |
TCMBANKIN059380 | aescin | escin _qt; CHEMBL1159567; escin; escin ia; escin iiia; aesci; saponins; Acid glycosides | C55H86O24 | 1131.3 g/mol | CC=C(C)C(=O)OC1C(C2(C(CC1(C)C)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)CO)OC6C(C(C(C(O6)C(=O)O)OC7C(C(C(C(O7)CO)O)O)O)O)OC8C(C(C(C(O8)CO)O)O)O)C)CO)OC(=O)C |
TCMBANKIN061029 | myristic acid | C14H28O2 | 228.37 | CCCCCCCCCCCCCC(=O)O |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
---|